K
Ksolves India Ltd
NSE:KSOLVES
Ksolves India Ltd
NSE:KSOLVES
Price:
268.3
INR
3.09%
Market Cap:
₹6.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Ksolves India Ltd
NSE:KSOLVES
|
IN |
|
Newmark Group Inc
NASDAQ:NMRK
|
US |
|
C
|
China Shineway Pharmaceutical Group Ltd
HKEX:2877
|
CN |
|
Ivanhoe Mines Ltd
TSX:IVN
|
CA |
|
C
|
Coral India Finance and Housing Ltd
NSE:CORALFINAC
|
IN |
|
S
|
Singapore Technologies Engineering Ltd
OTC:SGGKF
|
SG |
|
Checkpoint Therapeutics Inc
NASDAQ:CKPT
|
US |
|
S
|
SCG Packaging PCL
SET:SCGP
|
TH |
|
Orchid Pharma Ltd
NSE:ORCHPHARMA
|
IN |
|
Albany International Corp
NYSE:AIN
|
US |
|
AVG Logistics Ltd
NSE:AVG
|
IN |
|
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
SA |
Balance Sheet
Balance Sheet Decomposition
Ksolves India Ltd
Ksolves India Ltd
Balance Sheet Decomposition is not available for
Ksolves India Ltd
Ksolves India Ltd
Balance Sheet
Ksolves India Ltd
Ksolves India Ltd
Currency: INR
| Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
1
|
81
|
69
|
86
|
73
|
80
|
|
| Cash |
0
|
0
|
0
|
0
|
15
|
0
|
|
| Cash Equivalents |
1
|
81
|
69
|
86
|
58
|
80
|
|
| Short-Term Investments |
0
|
0
|
3
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
36
|
93
|
151
|
273
|
336
|
|
| Accounts Receivables |
0
|
36
|
93
|
151
|
161
|
211
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
113
|
125
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
6
|
37
|
57
|
83
|
14
|
26
|
|
| Total Current Assets |
7
|
155
|
222
|
320
|
361
|
467
|
|
| PP&E Net |
11
|
10
|
10
|
10
|
24
|
74
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
24
|
74
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
31
|
53
|
|
| Intangible Assets |
1
|
1
|
1
|
1
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Note Receivable |
2
|
4
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
2
|
4
|
0
|
13
|
|
| Other Long-Term Assets |
0
|
3
|
3
|
5
|
10
|
23
|
|
| Other Assets |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Assets |
21
N/A
|
172
+723%
|
237
+38%
|
341
+44%
|
396
+16%
|
564
+43%
|
|
| Liabilities | |||||||
| Accounts Payable |
3
|
1
|
6
|
5
|
3
|
4
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
90
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
1
|
0
|
15
|
|
| Other Current Liabilities |
9
|
35
|
56
|
99
|
133
|
159
|
|
| Total Current Liabilities |
11
|
36
|
63
|
103
|
137
|
276
|
|
| Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
37
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
3
|
7
|
14
|
21
|
44
|
|
| Total Liabilities |
12
N/A
|
39
+216%
|
70
+82%
|
117
+67%
|
157
+34%
|
356
+127%
|
|
| Equity | |||||||
| Common Stock |
0
|
15
|
119
|
119
|
119
|
119
|
|
| Retained Earnings |
9
|
119
|
48
|
105
|
120
|
89
|
|
| Total Equity |
9
N/A
|
134
+1 418%
|
167
+25%
|
224
+34%
|
238
+6%
|
208
-13%
|
|
| Total Liabilities & Equity |
21
N/A
|
172
+723%
|
237
+38%
|
341
+44%
|
396
+16%
|
564
+43%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
24
|
24
|
24
|
24
|
24
|
24
|
|
Switch to:
Switch to:
See Also
Discover More
